Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras‐Sanz, Kristan van der Vos, Daniël J. Vis, Linde M. Braaf, Annegien Broeks, Ron Kerkhoven, Kim E.M. van Kessel, María J. Ribal, Antonio Alcaraz, Lodewyk F.A. Wessels, Roland Seiler, Jonathan L. Wright, Lourdes Mengual, Joost L. Boormans, Bas W.G. van Rhijn, Peter C. Black, Michiel S. van der Heijden
Topics & Concepts
MedicineCisplatinBladder cancerChemotherapyOncologyInternal medicineUrothelial cancerNeoadjuvant therapyCancerBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments